N- (2- ((4- benzylpiperidin- 1- yl)methyl)benzimidazol- 5- yl)methanesulfonamide
inhibits GluN1 and GluN2B receptors; structure in first source
Also Known As:
XK1 compound
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results